Publicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (30)

2022

  1. A faecal microbiota signature with high specificity for pancreatic cancer

    Gut, Vol. 71, Núm. 7, pp. 1359-1372

  2. Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis

    eBioMedicine, Vol. 75

2021

  1. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses

    Gut, Vol. 70, Núm. 2, pp. 319-329

  2. Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), Vol. 30, Núm. 6, pp. 423-430

2019

  1. Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case–control approaches

    International Journal of Cancer, Vol. 144, Núm. 7, pp. 1540-1549

2018

  1. Increased plasma levels of galectin-1 in pancreatic cancer: Potential use as biomarker

    Oncotarget, Vol. 9, Núm. 68, pp. 32984-32996

2016

  1. Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models

    BMC Cancer, Vol. 16, Núm. 1

2012

  1. Pancreatic cancer risk and levels of trace elements

    Gut, Vol. 61, Núm. 11, pp. 1583-1588

2011

  1. Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: A prospective study in a clinically-relevant spectrum of patients

    European Journal of Epidemiology, Vol. 26, Núm. 3, pp. 229-236

  2. Urinary pH, cigarette smoking and bladder cancer risk

    Carcinogenesis, Vol. 32, Núm. 6, pp. 843-847

2010

  1. Occupational exposures and risk of pancreatic cancer

    European Journal of Epidemiology, Vol. 25, Núm. 10, pp. 721-730

  2. Risk assessment model for first-cycle chemotherapy-induced neutropenia in patients with solid tumours

    European Journal of Cancer Care, Vol. 19, Núm. 5, pp. 648-655

2009

  1. Lifetime history of alcohol consumption and K-ras mutations in pancreatic ductal adenocarcinoma

    Environmental and Molecular Mutagenesis, Vol. 50, Núm. 5, pp. 421-430

  2. Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: A hypothesis-generating study

    Cancer Causes and Control, Vol. 20, Núm. 5, pp. 591-599

2007

  1. Bladder cancer and exposure to water disinfection by-products through ingestion, bathing, showering, and swimming in pools

    American Journal of Epidemiology, Vol. 165, Núm. 2, pp. 148-156

  2. Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer

    Journal of Epidemiology and Community Health, Vol. 61, Núm. 7, pp. 641-649

  3. Lifetime history of tobacco consumption and K-ras mutations in exocrine pancreatic cancer

    Pancreas, Vol. 35, Núm. 2, pp. 135-141

2005

  1. Exocrine pancreatic cancer: Symptoms at presentation and their relation to tumour site and stage

    Clinical and Translational Oncology, Vol. 7, Núm. 5, pp. 189-197

2003

  1. Occupational exposure to dyes, metals, polycyclic aromatic hydrocarbons and other agents and K-ras activation in human exocrine pancreatic cancer

    International Journal of Cancer, Vol. 107, Núm. 4, pp. 635-641

2002

  1. Incomplete overlapping of biological, clinical, and environmental information in molecular epidemiological studies: A variety of causes and a cascade of consequences

    Journal of Epidemiology and Community Health, Vol. 56, Núm. 10, pp. 734-738